SAFETY OF BRONCHOALVEOLAR LAVAGE IN HEMATOLOGICAL PATIENTS WITH THROMBOCYTOPENIA – A RETROSPECTIVE COHORT STUDY

Background Hospitalized hematological patients often require bronchoalveolar lavage (BAL). Paucity of evidence exists as to the potential risks in patients with very-severe thrombocytopenia (VST). Methods This retrospective-cohort study included adult hematological in-patients with VST, de...

Full description

Saved in:
Bibliographic Details
Main Authors: Ivan GUR, Roei Tounek, Yaniv Dotan, Elite Vainer Evgrafov, Stav Rakedzon, Eyal Fuchs
Format: Article
Language:English
Published: PAGEPress Publications 2024-01-01
Series:Mediterranean Journal of Hematology and Infectious Diseases
Subjects:
Online Access:https://mjhid.org/mjhid/article/view/5506
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832544412959244288
author Ivan GUR
Roei Tounek
Yaniv Dotan
Elite Vainer Evgrafov
Stav Rakedzon
Eyal Fuchs
author_facet Ivan GUR
Roei Tounek
Yaniv Dotan
Elite Vainer Evgrafov
Stav Rakedzon
Eyal Fuchs
author_sort Ivan GUR
collection DOAJ
description Background Hospitalized hematological patients often require bronchoalveolar lavage (BAL). Paucity of evidence exists as to the potential risks in patients with very-severe thrombocytopenia (VST). Methods This retrospective-cohort study included adult hematological in-patients with VST, defined as platelets<20x103/μL, undergoing BAL during 2012-2021. Mechanically-ventilated patients or those with known active bleeding were excluded. Primary outcomes included major bleeding halting the BAL or deemed significant by the treating physician, need for any respiratory support other than low flow O2 or death within 24 hours. Any other bleeding were recorded as secondary outcomes.    Results Of the 507 patients included in the final analysis, the 281 patients with VST had lower hemoglobin (Md=0.3, p=0.003), longer prothrombin-time (Md=0.7s, p=0.025), higher chances of preprocedural platelet transfusion (RR 3.68, 95%CI[2.86,4.73]), and only one primary-outcome event (death of septic shock 21h postprocedurally) - compared with 3 (1.3%) events (two bleedings halting procedure and one need for non-invasive-ventilation) in patients with platelets ≥20x103/μL (p=0.219). Risk of minor, spontaneously resolved bleeding was higher (RR=3.217, 95%CI[0.919,11.262]) in patients with VST (4.3% vs 1.3%, p=0.051). No association was found between any of the complications recorded and preprocedural platelets, age, aPTT, PT, hematological status, or platelet transfusion.  Conclusions This data suggests BAL to be safe even when platelet counts are <20x103/μL.
format Article
id doaj-art-7bd55aa78fbf4d6dbd74008ad920f07a
institution Kabale University
issn 2035-3006
language English
publishDate 2024-01-01
publisher PAGEPress Publications
record_format Article
series Mediterranean Journal of Hematology and Infectious Diseases
spelling doaj-art-7bd55aa78fbf4d6dbd74008ad920f07a2025-02-03T10:29:29ZengPAGEPress PublicationsMediterranean Journal of Hematology and Infectious Diseases2035-30062024-01-0116110.4084/MJHID.2024.006SAFETY OF BRONCHOALVEOLAR LAVAGE IN HEMATOLOGICAL PATIENTS WITH THROMBOCYTOPENIA – A RETROSPECTIVE COHORT STUDYIvan GUR0Roei TounekYaniv DotanElite Vainer EvgrafovStav RakedzonEyal Fuchsa:1:{s:5:"en_US";s:24:"Rambam Healthcare Campus";} Background Hospitalized hematological patients often require bronchoalveolar lavage (BAL). Paucity of evidence exists as to the potential risks in patients with very-severe thrombocytopenia (VST). Methods This retrospective-cohort study included adult hematological in-patients with VST, defined as platelets<20x103/μL, undergoing BAL during 2012-2021. Mechanically-ventilated patients or those with known active bleeding were excluded. Primary outcomes included major bleeding halting the BAL or deemed significant by the treating physician, need for any respiratory support other than low flow O2 or death within 24 hours. Any other bleeding were recorded as secondary outcomes.    Results Of the 507 patients included in the final analysis, the 281 patients with VST had lower hemoglobin (Md=0.3, p=0.003), longer prothrombin-time (Md=0.7s, p=0.025), higher chances of preprocedural platelet transfusion (RR 3.68, 95%CI[2.86,4.73]), and only one primary-outcome event (death of septic shock 21h postprocedurally) - compared with 3 (1.3%) events (two bleedings halting procedure and one need for non-invasive-ventilation) in patients with platelets ≥20x103/μL (p=0.219). Risk of minor, spontaneously resolved bleeding was higher (RR=3.217, 95%CI[0.919,11.262]) in patients with VST (4.3% vs 1.3%, p=0.051). No association was found between any of the complications recorded and preprocedural platelets, age, aPTT, PT, hematological status, or platelet transfusion.  Conclusions This data suggests BAL to be safe even when platelet counts are <20x103/μL. https://mjhid.org/mjhid/article/view/5506Bronchoalveolar Lavage (BAL), Thrombocytopenia, Hematological patients, BAL complications
spellingShingle Ivan GUR
Roei Tounek
Yaniv Dotan
Elite Vainer Evgrafov
Stav Rakedzon
Eyal Fuchs
SAFETY OF BRONCHOALVEOLAR LAVAGE IN HEMATOLOGICAL PATIENTS WITH THROMBOCYTOPENIA – A RETROSPECTIVE COHORT STUDY
Mediterranean Journal of Hematology and Infectious Diseases
Bronchoalveolar Lavage (BAL), Thrombocytopenia, Hematological patients, BAL complications
title SAFETY OF BRONCHOALVEOLAR LAVAGE IN HEMATOLOGICAL PATIENTS WITH THROMBOCYTOPENIA – A RETROSPECTIVE COHORT STUDY
title_full SAFETY OF BRONCHOALVEOLAR LAVAGE IN HEMATOLOGICAL PATIENTS WITH THROMBOCYTOPENIA – A RETROSPECTIVE COHORT STUDY
title_fullStr SAFETY OF BRONCHOALVEOLAR LAVAGE IN HEMATOLOGICAL PATIENTS WITH THROMBOCYTOPENIA – A RETROSPECTIVE COHORT STUDY
title_full_unstemmed SAFETY OF BRONCHOALVEOLAR LAVAGE IN HEMATOLOGICAL PATIENTS WITH THROMBOCYTOPENIA – A RETROSPECTIVE COHORT STUDY
title_short SAFETY OF BRONCHOALVEOLAR LAVAGE IN HEMATOLOGICAL PATIENTS WITH THROMBOCYTOPENIA – A RETROSPECTIVE COHORT STUDY
title_sort safety of bronchoalveolar lavage in hematological patients with thrombocytopenia a retrospective cohort study
topic Bronchoalveolar Lavage (BAL), Thrombocytopenia, Hematological patients, BAL complications
url https://mjhid.org/mjhid/article/view/5506
work_keys_str_mv AT ivangur safetyofbronchoalveolarlavageinhematologicalpatientswiththrombocytopeniaaretrospectivecohortstudy
AT roeitounek safetyofbronchoalveolarlavageinhematologicalpatientswiththrombocytopeniaaretrospectivecohortstudy
AT yanivdotan safetyofbronchoalveolarlavageinhematologicalpatientswiththrombocytopeniaaretrospectivecohortstudy
AT elitevainerevgrafov safetyofbronchoalveolarlavageinhematologicalpatientswiththrombocytopeniaaretrospectivecohortstudy
AT stavrakedzon safetyofbronchoalveolarlavageinhematologicalpatientswiththrombocytopeniaaretrospectivecohortstudy
AT eyalfuchs safetyofbronchoalveolarlavageinhematologicalpatientswiththrombocytopeniaaretrospectivecohortstudy